BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 2:47:00 PM | Browse: 1299 | Download: 1152
 |
Received |
|
2013-12-26 09:01 |
 |
Peer-Review Started |
|
2013-12-27 14:38 |
 |
To Make the First Decision |
|
2014-02-27 11:22 |
 |
Return for Revision |
|
2014-03-06 09:04 |
 |
Revised |
|
2014-03-21 16:18 |
 |
Second Decision |
|
2014-05-14 16:32 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-05-14 16:46 |
 |
Articles in Press |
|
2014-05-23 09:03 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-07-17 13:46 |
 |
Publish the Manuscript Online |
|
2014-08-20 20:27 |
Category |
Cardiac & Cardiovascular Systems |
Manuscript Type |
Topic Highlights |
Article Title |
Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis
|
Manuscript Source |
Invited Manuscript |
All Author List |
Hiroshi Satoh, Makoto Sano, Kenichiro Suwa, Takeji Saitoh, Mamoru Nobuhara, Masao Saotome, Tsuyoshi Urushida, Hideki Katoh and Hideharu Hayashi |
Funding Agency and Grant Number |
|
Corresponding Author |
Hiroshi Satoh, MD, PhD, Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ward, Hamamatsu 431-3192, Japan. satoh36@hama-med.ac.jp |
Key Words |
Cardiomyopathy; Cardiac magnetic resonance; Late gadolinium enhancement; Cardiac function; Clinical features; Prognosis |
Core Tip |
We review characteristic cardiac magnetic resonance (CMR) features in ischemic and non-ischemic cardiomyopathies (NICM), especially in terms of location and distribution of late gadolinium enhancement (LGE). LGE in NICM does not correspond to any particular coronary artery distribution and is located mostly in the mid-wall to subepicardial layer. The analysis of LGE distribution is valuable to differentiate NICM with diffusely impaired systolic function; dilated cardiomyopathy, end-stage hypertrophic cardiomyopathy (HCM), cardiac sarcoidosis, and myocarditis, and those with diffuse LV hypertrophy; HCM, cardiac amyloidosis and Anderson-Fabry disease. The analyses of LGE distribution have potentials to predict cardiac outcomes and response to treatments. |
Publish Date |
2014-08-20 20:27 |
Citation |
Satoh H, Sano M, Suwa K, Saitoh T, Nobuhara M, Saotome M, Urushida T, Katoh H, Hayashi H. Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis. World J Cardiol 2014; 6(7): 585-601 |
URL |
http://www.wjgnet.com/1949-8462/full/v6/i7/585.htm |
DOI |
http://dx.doi.org/10.4330/wjc.v6.i7.585 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345